Mi-Trial is partnering with the PULSE-CF Innovation Hub, supported by the Cystic Fibrosis (CF) Trust, on a national study of infection and exacerbations in CF.

The CF Trust is the UK’s leading charity dedicated to improving the lives of people affected by cystic fibrosis, funding vital research, supporting clinical care, and advocating for better treatment and support for the CF community. 

At Mi-Trial, we are proud to see our leadership actively supporting initiatives which drive progress in respiratory medicine and rare disease research. Collaboration between charities, researchers, clinicians, and industry is essential to delivering the next generation of therapies for people living with CF.

We look forward to continuing to support advances in clinical research which improve patient outcomes.